The price of Clover Health Investments Corp (NASDAQ:CLOV) shares last traded on Wall Street rose 1.96% to $1.04.
Based on available information, 3 analysts follow Clover Health Investments Corp (NASDAQ:CLOV). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $2.00 and a low of $1.00, we find $1.00. Given the previous closing price of $1.02, this indicates a potential downside of -1.96 percent. CLOV stock price is now -0.50% away from the 50-day moving average and 0.46% away from the 200-day moving average. The market capitalization of the company currently stands at $507.15M.
Among analysts, 2 rate the stock a hold while 1 rate it a buy. Brokers who have rated the stock have averaged $1.33 as their price target over the next twelve months.
With the price target reduced from $7 to $3, Cowen Upgraded its rating from Underperform to Market Perform for Clover Health Investments Corp (NASDAQ: CLOV).
In other news, Loengard Anna U, Director bought 11,000 shares of the company’s stock on Sep 06. The stock was bought for $14,300 at an average price of $1.30. Upon completion of the transaction, the Director now directly owns 10,000 shares in the company, valued at $10400.0. Insiders disposed of 1,799,897 shares of company stock worth roughly $1.87 million over the past 1 year. A total of 24.04% of the company’s stock is owned by insiders.
A candlestick chart of Clover Health Investments Corp (NASDAQ: CLOV) showed a price of $1.0100 on Thursday morning. During the past 12 months, Clover Health Investments Corp has had a low of $0.71 and a high of $1.63. The fifty day moving average price for CLOV is $1.0453 and a two-hundred day moving average price translates $1.0352 for the stock.
The latest earnings results from Clover Health Investments Corp (NASDAQ: CLOV) was released for Sep, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.09, beating analysts’ expectations of -$0.11 by 0.02. This compares to -$0.16 EPS in the same period last year. The net profit margin was -9.37% and return on equity was -63.58% for CLOV. The company reported revenue of $482.07 million for the quarter, compared to $856.82 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -43.74 percent. For the current quarter, analysts expect CLOV to generate $478.75M in revenue.
Clover Health Investments Corp(CLOV) Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.
